Semaglutide is a lab-engineered peptide that acts as a GLP-1 (glucagon-like peptide-1) receptor agonist. In preclinical and clinical research, it has been studied for its effects on glucose control, appetite signaling, and digestive system activity. Research models examine how it influences metabolic function, including energy balance and insulin response pathways.

For Research Use Only. Not intended for human consumption, medical, diagnostic, or therapeutic purposes.